Related Experiment Video
Updated: Feb 25, 2026

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
Management of common variable immunodeficiency by subcutaneous IgG self-administration during pregnancy - a case
Carolina Marasco1, Alberta Venturelli1, Luigia Rao1
1Department of Biomedical Sciences and Human Oncology Unit of Internal Medicine "G. Baccelli" "Aldo Moro" University of Bari Medical School Policlinico Piazza Giulio Cesare 11 I-70124 Bari Italy.
Abstract:
Patients with common variable immunodeficiency are prone to infections, and this poses a particular challenge during pregnancy, when the requirement for immunoglobulin (Ig) replacement therapy is even more demanding so as to achieve an effective protection also of the fetus. This case report highlights the benefits observed with subcutaneous IgG self-administration in the management of common variable immunodeficiency (CVID) during pregnancy, in terms of efficacy and safety.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Intrauterine Drug Delivery Systems
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Hypersensitivity Reactions: Immune-Complex Reactions